Share Price, page-3727

Hi Snozz, understand your frustration and confusion on this. I was also puzzled initially at the strange behaviour in Neuren's share price. Whenever good news was announced the share price would inevitably and reliably drop. Makes you wonder if someone smarter does know something we don't. Am I being duped into buying into something that isn't really as good as it looks?

However, I've been in Neuren for 7 years now and am used to this. At no time did a big share price drop turn out to be based upon something hidden. For example, the price went down and down before Ph 3 results - suggesting a bad result was expected. But - the results were actually great, and you would have quadrupled your money if you bought in ahead of the announcement.

Like you I also wondered why others didn't invest and push the price up if Neuren was such a good opportunity. However, I've now spent the last 7 years becoming a 'lay expert' in Neuren and orphan drug pharma in general and have far more confidence.

In summary, this behaviour is entirely normal for Neuren - its a small not well known Australian Pharmaceutical which is pre-revenue - no approved drugs yet. So from a wider market perspective its simply not yet valuable.

But this is why those that know Neuren well have a remarkable opportunity - to making a significant financial gain from market-mis pricing where our downside risk is much lower than the wider market thinks.

The opportunity to triple your investment doesn't come with a 'normally behaving' share.

All the best